BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• VolitionRX Announces Proposed Public Offering Of Common Stock

  September 30, 2016

   · 

  5 min read
• Drug Development

  Arbutus Biopharma Reports Interim Multi-Dose Results From Phase II Clinical Trial Of ARB-1467 In Patients With Chronic HBV Infection

  September 30, 2016

   · 

  6 min read
• Business

  Schulman IRB’s Central Oncology Review (COR) Division Adds Another Institutional Research Leader To Team

  September 30, 2016

   · 

  3 min read
• Bio NC

  LabCorp Subsidiary Sequenom Announces Early Tender Results For Tender Offers And Successful Completion Of Consent Solicitations For 5% Convertible Senior Notes Due 2017 And 5% Convertible Senior Exchange Notes Due 2018

  September 30, 2016

   · 

  5 min read
• Pharm Country

  Delcath Systems Prices Underwritten Public Offering Of Common Stock And Warrants

  September 30, 2016

   · 

  5 min read
• Pharm Country

  Delcath Systems Announces Proposed Public Offering Of Common Stock And Warrants

  September 30, 2016

   · 

  5 min read
• Endo Pharma Presents New Phase 2 Data Evaluating The Safety And Effectiveness Of XIAFLEX (Collagenase Clostridium Histolyticum) For Dupuytren’s Disease Nodules

  September 30, 2016

   · 

  14 min read
• Job Trends

  BIOTRONIK Begins Manufacturing High-Tech Products In Singapore

  September 30, 2016

   · 

  2 min read
• Drug Development

  Quantum Genomics Corp. Reports Positive Top-Line Results From Phase IIa Trial Of QGC001 In Hypertension

  September 30, 2016

   · 

  3 min read
• FDA

  ProAxsis Gains CE Mark For Active Neutrophil Elastase Immunoassay

  September 30, 2016

   · 

  2 min read